JCIC Asset Management’s GSK GSK Stock Holding History

JCIC Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-253	Closed	-$15K	–	109
2019 Q4	$15K	Buy	+253	New	+$14.1K	0.01%	91
2019 Q2	–	Sell	-302	Closed	-$16K	–	134
2019 Q1	$16K	Buy	+302	New	+$15.1K	0.01%	87
2016 Q3	–	Sell	-1,100	Closed	-$60K	–	54
2016 Q2	$60K	Hold	1,100	–	–	0.02%	42
2016 Q1	$56K	Hold	1,100	–	–	0.02%	47
2015 Q4	$55K	Hold	1,100	–	–	0.02%	51
2015 Q3	$53K	Hold	1,100	–	–	0.01%	53
2015 Q2	$57K	Sell	1,100 -124	-10%	-$6.98K	0.01%	57
2015 Q1	$71K	Hold	1,224	–	–	0.01%	53
2014 Q4	$65K	Hold	1,224	–	–	0.01%	48
2014 Q3	$70K	Sell	1,224 -268,024	-100%	-$16.4M	0.01%	46
2014 Q2	$18M	Buy	269,248 +1,988	+0.7%	+$135K	3.01%	12
2014 Q1	$17.9M	Sell	267,260 -105,028	-28%	-$7.1M	3.26%	14
2013 Q4	$24.8M	Sell	372,288 -35,972	-9%	-$2.33M	4.8%	6
2013 Q3	$25.6M	Buy	408,260 +80,244	+24%	+$5.17M	4.6%	6
2013 Q2	$20.5M	Buy	+328,016	New	+$20.8M	3.99%	8

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

JCIC Asset Management's GSK Position: Q1 2020 in Review

JCIC Asset Management sold out of GSK (GSK) in Q1 2020, closing a stake of 253 shares — an estimated $15K sold.

JCIC Asset Management first reported a position in GSK in Q2 2013 and held it in 15 quarters. The position peaked at $25.6M in Q3 2013. 817 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

JCIC Asset Management reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
JCIC Asset Management sold 253 GSK shares in Q1 2020, an estimated $15K.
JCIC Asset Management first reported a position in GSK in Q2 2013 and held it in 15 quarters.
JCIC Asset Management's GSK position peaked at $25.6M in Q3 2013.
817 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on JCIC Asset Management's 13F filing for Q1 2020, filed 17 Apr 2020.